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The SARS coronavirus (SARS-CoV) spike is the largest known viral spike molecule, and shares a similar function with all class 1
viral fusion proteins. Previous structural studies of membrane fusion proteins have largely used crystallography of static
molecular fragments, in isolation of their transmembrane domains. In this study we have produced purified, irradiated SARS-
CoV virions that retain their morphology, and are fusogenic in cell culture. We used cryo-electron microscopy and image
processing to investigate conformational changes that occur in the entire spike of intact virions when they bind to the viral
receptor, angiotensin-converting enzyme 2 (ACE2). We have shown that ACE2 binding results in structural changes that appear
to be the initial step in viral membrane fusion, and precisely localized the receptor-binding and fusion core domains within the
entire spike. Furthermore, our results show that receptor binding and subsequent membrane fusion are distinct steps, and that
each spike can bind up to three ACE2 molecules. The SARS-CoV spike provides an ideal model system to study receptor binding
and membrane fusion in the native state, employing cryo-electron microscopy and single-particle image analysis.
Citation: Beniac DR, deVarennes SL, Andonov A, He R, Booth TF (2007) Conformational Reorganization of the SARS Coronavirus Spike Following
Receptor Binding: Implications for Membrane Fusion. PLoS ONE 2(10): e1082. doi:10.1371/journal.pone.0001082
INTRODUCTION
Viral membrane fusion proteins are responsible both for binding
to cellular receptors, and the subsequent fusion of viral and cellular
membranes. The paradigm for class I fusion proteins consists of
two heptad repeat regions, and a hydrophobic fusion peptide [1].
This motif is present in SARS-CoV [2] and other coronaviruses
[3], as well as the hemagglutinin (HA) of influenza [4], gp21 of
human T-cell leukemia virus type 1[5], gp41 of HIV[6], GP2 of
Ebola virus [7,8], and the fusion protein of paramyxovirus [9–12].
Class I viral fusion proteins can also be divided into two sub-types;
those whose fusion mechanism is low pH-dependent such as
influenza HA, and those that are pH-independent like the
retroviral fusion proteins. In retroviruses, receptor binding itself
can trigger fusion, with temperature and redox conditions also
influencing the fusion mechanism [13,14]. The SARS spike
appears to be insensitive to redox conditions [15]. For SARS-CoV,
it is proposed that the virus is internalized in the cell by
endocytosis, and is then exposed to a low pH environment, and
it is postulated that proteolytic cleavage between the S1 and S2
domains initiates the membrane fusion process [16]. Although the
factors which trigger fusion (endocytosis, pH sensitivity, single
receptor vs. primary and co-receptor binding, redox change) differ
amongst diverse virus families, all viral fusion proteins are thought
to share the same basic fusion mechanism [1,4,17–20].
A notable feature of the SARS spike is its large mass (,500 kD
per trimer) and striking, club-shaped appearance, from the end-on,
this appears like a three-bladed propeller with a radius of 90 A ˚
[21]. Despite the structural differences, the SARS spike performs
the same fundamental task in viral entry to the host cell as other
class I viral fusion proteins, such as the influenza HA (,220 kD
per trimer). The SARS spike can be subdivided into four structural
domains (from N to C terminus); the two large external domains
S1 and S2 are largely responsible for receptor binding and
membrane fusion, respectively. In many class I viral fusion
proteins the analogous peptides are generated by proteolysis of the
spike precursor during the maturation process in the host cell,
resulting in two peptides with the fusion peptide on the N-terminus
of S2. In SARS-CoV the S1/S2 assignment is given based on
sequence homology to other viral fusion proteins, however there is
no peptide cleavage during maturation. The final two small
domains are comprised of a transmembrane domain, and
a carboxyterminal cytoplasmic domain, which principally anchor
thespiketotheviralenvelope.Thecell-surfacemoleculeACE2isthe
receptor for the SARS spike protein [22] and is a relatively large
macromoleculewith a diameter of70 A ˚. Incomparison,thereceptor
for influenza HA, sialic acid, is much smaller with a 10 A ˚ diameter.
The precise mechanisms by which class I viral fusion proteins gain
access to the host cell remain unknown. The hypothetical entry
process includes several steps that take place in sequence: receptor
binding, fusion core re-arrangement, fusion peptide insertion in host
cell membrane, refolding of heptad repeats, membrane fusion, and
finally viral nucleocapsid transfer [23].
The structures of ACE2 bound to a fragment of the SARS spike
containing the receptor-binding domain and the pre- and post-
fusion configurations of the fusion core heptad repeats of the spike
have been solved to atomic resolution [2,3,24–26]. In addition, the
atomic resolution structures of two neutralizing antibodies bound
to the SARS spike receptor-binding domain have been solved
[27,28] showing that blocking of the receptor binding domain,
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mechanism of virus neutralization by these antibodies. The aim of
the present study was to delineate any possible structural changes
in the SARS spike that accompanied receptor-binding, and to
precisely localize the receptor binding domains (which are only
14% of the total mass of the spike) within the overall structure,
employing cryo-EM and image processing of intact virions bound
to soluble ACE2. We demonstrate the structural dynamics which
accompany spike-receptor binding, which may be involved in
triggering membrane fusion.
RESULTS
To study the structure of the spike-ACE2 complex, we infected
Vero E6 cells with SARS-CoV and purified supernatant virus by
iodoxanol density gradient centrifugation. Previously, we have
shown that specimens could be c-irradiated with a sufficient dose
(2Mrad) for viral inactivation, while still preserving protein
antigenicity. Inactivation was verified by passage in cell culture
and testing by quantitative PCR [29]. Purified c-irradiated SARS-
CoV preparations had a fusogenic activity when added to Vero E6
cells at high multiplicity (,500–3000 virions per cell), causing the
formation of syncytia in the absence of replication or cytopathic
effects (Figure 1A). These syncytia had identical morphology to
those observed in cytopathic studies of SARS-CoV in tissues and
in tissue cultured cells; syncytia have also been observed upon
expression of coronavirus S protein, or following addition of cells
expressing the S-protein to cells with surface-expressed ACE2.
[22,30–34]. The same inactivated c-irradiated virus preparations
were incubated with a human ACE2-human Fc chimeric protein,
for analysis of the complex by cryo-EM, 3D image processing, and
immuno-electron microscopy (immuno-EM) (Figure 1, Movie S1).
The ACE2-Fc construct was selected since it is soluble and
dimeric, and it was anticipated that the additional mass was would
be beneficial in locating the receptor attached to the spike.
Immuno-EM confirmed that recombinant ACE2 protein bound to
virions, and that binding affinity was not affected by c-irradiation
(Figure 1B). We did not observe any structural changes associated
with prior irradiation. Image averaging further suppressed any
possible random radiation induced structural changes.
Cryo-EM reconstructions of SARS-CoV and ACE2
bound to SARS-CoV
Cryo-EM coupled with 3D single particle image analysis was
employed to investigate the binding of ACE2 to the spike of
SARS-CoV. Although SARS-CoV is approximately spherical
when observed by cryo-EM, both its size and shape vary slightly,
and thus it is not amenable to single-particle averaging techniques.
However, individual spikes on the surface envelope of the virus do
provide a repetitive structure that is ideal for single particle
techniques. Spikes on the surface of virus particles are readily
imaged by cryo-EM in the frozen-hydrated state (Figure 1C).
Three-dimensional image processing was carried out on 11,153
selected spike images taken at various defocus levels, using routine
single-particle image processing [35,36]. The resolution of the final
3D structure was evaluated by a Fourier shell correlation of 0.5 to
be 18.5 A ˚ (Figure 2). The structure of the unbound spike was
compared with that of the spike-ACE2 complex (Figures 1E, 1F, 3,
Figure 1. Imaging SARS-CoV, Vero E6 cells, and ACE2. (A) Vero E6 cells stained with propidium iodide. Light microscopy shows a syncytium (white
arrow) in the center of the field of view (top), viewed under propidium iodide fluorescence (middle), and an overlay of both images (bottom). (B)
Immuno-EM with 10 nm gold confirmed the attachment of ACE2 to the spikes. (C) Cryo-EM field of view of SARS-CoV decorated with ACE2, and select
two-dimensional class averages of the SARS spike-ACE2 complex (D). Cryo-EM reconstruction of the SARS spike (E), and SARS spike-ACE2 complex (F),
viewed from side and end-on perspectives (left, right). Color scheme: ACE2, violet; spike, green; stalk, blue; envelope, beige; nucleocapsid, red. Scale
bars: (A) 50 mm, (B,C) 1000 A ˚, (D–F) 100 A ˚.
doi:10.1371/journal.pone.0001082.g001
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fairly similar, indicating that ACE2 binding does not result in
a fundamental structural unfolding of the spike. However, the
overall height of the spike was reduced from 160 A ˚ to 150 A ˚
following ACE2 binding. When viewed from the end-on
perspective and the spike undergoes a rotation of ,5u following
binding (Movie S2), and the mass at the center of the axis of
symmetry on the distal end of the spike redistributes itself from one
small central blob to three blobs or nubs (Figure 3 F,J). These
redistributions of mass can be further identified in difference maps
between the two reconstructions (Figure 3). Figure 3 B,G show
that the unbound spike undergoes a decondensation of mass
around the central axis (blue) upon ACE2 binding. This region is
the putative location of the S2 domain. Whereas, Figure 3 D,I
show that the bound spike difference map included both the ACE2
component (purple) and a re-arrangement of the outer edges of the
three ‘‘blades’’ of the S1 domain (green).
The precise location of ACE2 binding on the distal end of the
spike is centered at 70 A ˚ from the central axis of the spike, with
a3 0A ˚ gap between the axis of symmetry and ACE2. One ACE2
molecule was bound to each of the three propeller-like blades of
the spike, making a structure 220 A ˚ high (Figure 1F). The density
of these ACE2 molecules is high in the 3D density map, indicating
a high occupancy of binding sites. In addition, the structure shows
that binding of one ACE2 to the spike would not sterically hinder
binding of additional ACE2 molecules on the other two propeller-
blades of each trimer.
Docking atomic structures to cryo-EM
reconstructions
The cryo-EM 3D structures of the spike and the spike-ACE2
complex were combined with the atomic resolution structures of the
SARS spike receptor-binding domain- ACE2 complex [24] and the
heptad repeat pre- and post-fusion cores [2,25] to interpret the cryo-
EM structure. The receptor-binding domain- ACE2 data were
docked with a correlation score of 0.965 using the SITUS software
package (Figure 4) [37]. As expected the receptor-binding domain
docked to the distal end of the spike with ACE2 filling the extra mass
onthespike (shownby thecolor violet inFigure4).The emptyupper
region of the mass is likely composed of the Fc component of the
chimeric protein. Although this chimeric molecule is dimeric, only
one leg of the ACE-2 is able to bind to each of the three receptor
binding domains of the trimer. We anticipate the mass distal to the
hinge region to be flexible, and therefore components were blurred
out in the averaging process, leaving only a portion of the additional
mass in the 3-D map. The C-terminus of the docked ACE2 is in
a location consistent with this interpretation. Previously we modeled
the putative location of the receptor-binding domain and ACE2 in
the cryo-EM structure of the unbound spike using solely the
receptor-binding domain atomic resolution data [21]. In the present
study, we have shown that our previous prediction of the location of
the receptor-binding domain was only partially correct. The actual
location ofthe receptorbindingdomain and ACE2areinfactshifted
Figure 2. Estimate of resolution of the SARS spike-ACE2 complex. The
resolution was estimated by Fourier shell correlation (FSC) between two
half reconstructions of the SARS spike-ACE2 complex. The resolution was
estimated to be 18.5 A ˚ using the 0.5 FSC criteria (red dotted red line).
doi:10.1371/journal.pone.0001082.g002
Figure 3. Cryo-EM difference maps. The cryo-EM reconstruction of the SARS spike (A,F) was subtracted from the SARS spike-ACE2 complex (E,J). The
positive component attributed to the SARS spike in (B,G) indicates a re-arrangement in the S2 core, and the positive component attributed the SARS-
CoV–ACE2 complex shows the addition of ACE2 and an exterior re-arrangement in S1 (D,I). The net difference map is presented in (C,H). The
structures are presented from a side perspective (A–E), and end-on perspective (F–J). The arrows in (F) and (J) illustrate the mass reorganization that
occurs in the central axis of the spike where one small central blob splits into three nubs. In (A,F) the region on the spike adjacent to ACE2 which
corresponds to the receptor binding domain, has been highlighted with a dotted line and is colored purple. The color scheme used for the cryo-EM
structure is the same as in Figure 1. Scale bar, 100 A ˚.
doi:10.1371/journal.pone.0001082.g003
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diameter of ACE2. The results from the present study will aid in the
preciselocation offutureatomicresolutionstructurefragmentsofthe
SARS spike, as well as in the structural mapping of neutralizing
antibody-binding epitopes (which are in progress). The coordinates
of the three dimensional reconstruction of the SARS spike (EMD-
1423) and the SARS spike-ACE2 complex (EMD-1425) have been
deposited in the macromolecular database (http://www.ebi.ac.uk/
msd).
DISCUSSION
Our cryo-EM results demonstrate that there is a structural
transition of the spike that occurs upon receptor binding (Figure 3,
Movie S2). The overall height of the spike is reduced by 10 A ˚ due
to a shift in the mass in the S1 domain (Figure 3 D,I) and the three
S1 blades of the spike twist ,5u along the axis of symmetry. On
the distal end of the spike, a small blob feature is replaced by three
small nubs which appear radially. (Figure 3 F,J). We propose that
this structural re-arrangement represents an initial ‘‘priming’’ of
the spike for membrane fusion, which brings the cellular and viral
membranes 10 A ˚ closer to each other to facilitate fusion. The
coronavirus S protein is known to mediate both virion-cell
membrane fusion, and intercellular membrane fusion [22,30–33]
and in the present study we have shown that purified inactivated
virions are also fusion-competent. We show that the addition of
SARS-CoV virions to cultured cells that express ACE-2 can
induce fusion, presumably from the fusion activity of spikes on
virions bridging neighboring cells. Similar observations on the
induction of ‘‘fusion-from-without’’ were made when cells surface-
expressing the spike protein were mixed with cells expressing
ACE-2 [35]. The trigger that initiates membrane fusion varies
amongst class I fusion proteins, with some activated by receptor
binding, others by pH, and others by redox conditions. In most
proposed models of membrane fusion it is postulated that the S1
domain or analogous receptor binding domains dissociate from the
spike during the membrane fusion process. This dynamic process
was demonstrated for influenza HA by Kemble et al. [38] in their
investigation where they engineered intermonomer disulfide bonds
between the HA S1 subunits. The result of this was that fusion
activity was impaired; however it could be restored under reducing
conditions. It is likely that the SARS spike shares a similar
mechanism, and the structural changes that we have detected
represent the initial step in this process.
By analogy with other class I viral fusion proteins, we anticipate
that the fusion core of the SARS spike must undergo similar
structural re-arrangements during fusion. The receptor-binding
domain is localized in a position on the distal end of the molecule,
closer to the 3-fold axis than anticipated, yet still in a position that
would not impede these structural re-arrangements. Putative
mechanisms by which class I viral fusion proteins achieve
membrane fusion have been proposed [1,4,17–19], but complete
structural evidence for the role of intermediate structures in these
mechanisms has yet to be obtained. The structural biology of this
process has been best characterized for the influenza hemagglu-
tinin, and paramyxovirus fusion (F) protein, for which the pre-
fusion and membrane fusion pH structures have been determined
by X-ray crystallography [4,11,12,39,40]. All of the subsequent
models for class I viral fusion proteins are based on the structural
data of these two fusion proteins. A drawback in all of these models
is that they are based on recombinant ectodomains that are not
proven to exist as a component in the complete molecule, and they
lack both membrane-interacting residues, and lipids [4]. The cryo-
EM structures presented in this investigation are of intact SARS
spike bound to native virion lipid envelopes. The cryo-EM data
are very instructive when atomic resolution fragments are docked
within the overall molecule, especially as the entire SARS spike
has proven to be a difficult subject for X-ray crystallography, and
atomic resolution data exist for only a few fragments of the SARS
spike. Our cryo-EM results show that it is possible for the spike to
attach to three ACE2 receptors at once; this may serve to hold on
to the host membrane like a tripod so as to accurately orientate the
fusion core. In addition the 30 A ˚ gap between the axis of symmetry
and ACE2 provides sufficient space for fusion core rearrangement.
Damico et al., [14] demonstrated that the kinetics of binding of the
Rous sarcoma virus envelope protein to its receptor suggested that
binding of each spike molecule to multiple receptor monomers
occurred. It may therefore be possible that other structurally
homologous viral envelope proteins can also bind multiple
receptors, and this may be a general adaptation that provides
the correct temporal and spatial arrangement to bring about
membrane fusion. The observation that the SARS spike could bind
three soluble ACE2 receptors provides three possible binding states
with one, two or three membrane-bound receptors attached to the
spike. With one or two receptors bound, the spike and virus have
a wide range of movement possible. Whereas, in the case of three
bound receptors the spike and its fusion core will be arranged
perpendicular to the cell surface with minimal movement possible. It
is interesting to note that binding three receptors is the minimum
number of binding events required to achieve this perpendicular
orientation in three dimensional space. This observation matches up
with the conserved trimeric structures of class I fusion proteins which
are common amongst enveloped viruses, thus indicating a possible
conserved structural-functional relationship may exist. Another line
of reasoning is that oligomerisation favors a better ‘‘chance’’ of
successful receptor binding and subsequent insertion of the fusion
peptideintothehostmembrane.Accordingtothismodel,oligomeric
multiples higher then three would be favored, whereas the ‘‘tripod’’
model of receptor binding favors the conserved trimeric structures of
class I viral fusion proteins.
In Figure 3 we have we have presented the ACE2–SARS
structures as they were solved in this cryo-EM investigation. For
other fusion proteins like influenza HA1 and HIV GP120 it has
been modeled that the re-arrangements upon membrane fusion
are dramatic involving a shedding of the above mentioned
domains. In this investigation we have detected structural
movement of S1 upon ACE2 binding. This could represent the
initial phase of this dramatic process that is followed by fusion core
Figure 4. Merging cryo-EM and atomic resolution 3D structures. The
atomic resolution structures; PDB ID code, 2AJF (ACE2, blue; receptor-
binding domain, red) and PDB ID code, 2FXP (yellow) were docked
within the SARS spike-ACE2 complex using SITUS. The SARS spike-ACE2
complex is shown from (A) side and (B) end-on perspectives, the arrow
points to the C-terminus of ACE2. The color scheme used for the cryo-
EM structure is the same as in Figure 1. Scale bar, 100 A ˚.
doi:10.1371/journal.pone.0001082.g004
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brane, refolding of heptad repeats, and finally membrane fusion.
Analyzing the structure of the spike-receptor complex is
essential to understanding how viruses can adapt to utilize
receptors from different species and how they may evolve to gain
specificity for new receptor types. RNA viruses have a high rate of
mutation and recombination [41]. In SARS coronaviruses, the
spike is able to retain specific binding affinity for the ACE2 of
more than one host species, and rapid evolution to gain specificity
for novel ACE2 species has been demonstrated [42,43]. The
structure and large size of the spike of coronaviruses appears to be
an adaptation related to utilization of large host cell-surface
molecules such as ACE2 as specific receptors. Amongst the
Coronavirus family, specific cell surface receptors for the spike
protein are all in the range of 60–110 kD [44]. These large host
receptor molecules are in turn functionally constrained and thus
conserved across species barriers. In utilizing binding to a large
receptor molecule, it may be important that the spike S1 domain
also acts as a ‘‘spacer arm’’ holding the receptor far enough away
from the three-fold axis of symmetry of the spike S2 domain to
permit fusion core re-arrangement and subsequent membrane
fusion. Such a property necessitates having a large spike molecule.
Moreover, multiple receptor binding may have functional
significance, enhancing the binding and entry of viruses. Cross-
linking of adjacent host receptor molecules could increase the
affinity of the virus for its target cell, as well as improving the
kinetics of fusion. The SARS spike-ACE2 complex is an ideal
model system for the investigation of class I viral fusion protein
dynamics, utilizing cryo-EM to investigate fusion protein binding
and structural changes in the native state, within virion
membranes that are fusogenic. The presence of a common cell
fusion mechanism shared by diverse virus families holds the
prospect of developing broad-spectrum anti-virals that target these
conserved mechanisms, as well as the potential use of these
fusogenic proteins in drug delivery systems.
MATERIALS AND METHODS
Cells and viruses
SARS-CoV (Tor3 strain) was inoculated onto Vero E6 cells grown
in Dulbecco’s modified eagle medium supplemented with 10%
foetal bovine serum, 100 U/ml penicillin, 100 mg/ml streptomy-
cin, and 0.22 mg/ml l-glutamine at 37uC with 5% CO2. Cell
supernatant was harvested (300 ml) with a SARS-CoV TCID50
titre of 5610
7/ml and virus was pelleted using a Beckman SW32
rotor at 28000 rpm for 90 minutes. The virus pellet was
resuspended in PBS buffer, layered onto of a 12–30% iodoxanol
gradient (Optiprep) and centrifuged in a SW40 rotor at
38000 rpm for 2.5 hours. Fractions (0.7 ml) were collected from
the gradient with an Auto Densi-Flow gradient collector (Labcono)
and dialyzed against PBS. SARS-CoV-enriched fractions were
checked by SDS-Page and Western blotting, and rendered non-
infectious by irradiation in a gamma cell on dry ice with a 2Mrad
exposure for 90 minutes. Irradiated specimens were tested for
infectivity by inoculation onto Vero E6 cells, and examined for
cytopathogenic effects for 10 days, followed by blind passage of the
cells and testing for the growth of SARS-CoV by PCR [29].
To test for spike fusogenic activity Vero E6 cells were cultured
in 96 well plates (Corning). Once the cells were confluent the
medium was removed from each well and 20 ml of gamma
irradiated SARS-CoV containing 10
10 pfu/ml diluted 1:1 and 1:9
in culture media. The virus dilutions were incubated with the cells
for 1 hour at 37uC. After the incubation the plates were washed
three times with fresh culture medium to remove unbound virus.
The vero E6 cells were observed by light microscopy 2 and 4 days
post treatment for the presence of syncytia. Virus growth was not
detected at either dilution of irradiated virus, and no cytopathic
effect was observed. The presence of nucleic acid in syncytia was
investigated by propidium iodide staining and observation by
fluorescence microscopy.
Immuno-electron microscopy
The human ACE2-Fc (human IgG1) recombinant protein
(Adipogen) had an initial concentration of 1 mg/ml in PBS and
was diluted 1:10 in PBS for incubation with SARS-CoV, for the
remainder of this document this is referred to as ACE2. 2 mlo f
SARS-CoV were injected into 4 ml of PBS on a formvar-carbon
coated 400-mesh nickel grid, and incubated for 1 minute. All
incubations were carried out at 20uC. Grids were then washed in
PBS six times for 1 minute, followed by a 10-minute block in PBS-
G-BSA (PBS pH7.2, 0.2% glycine, 2% BSA). Grids were then
washed in PBS-G (PBS pH7.2, 0.2% glycine) six times for
1 minute, followed by a 1-hour incubation on a 20 ml drop of
ACE2. Grids were then washed in PBS-G (PBS pH7.2, 0.2%
glycine) six times for 1 minute, followed by a 1-hour incubation
with rabbit anti-human ACE2 polyclonal IgG (AdipoGen; diluted
1:200 in PBS). Grids were then washed in PBS-G (PBS pH7.2,
0.2% glycine) six times for 1 minute, followed by a 30 minute
incubation with goat anti-rabbit IgG (conjugated to 10 nm gold,
Sigma; diluted 1:10 in PBS). Grids were then washed in PBS-G
(PBS pH7.2, 0.2% glycine) three times for 1 minute. Grids were
fixed for 2 minutes (1% paraformaldehyde, 2% glutaraldehyde in
PBS), washed in deionised water and negatively stained with 2%
methylamine tungstate (Nanoprobes), and observed by trans-
mission electron microscopy in a Tecnai 20 G2 transmission
electron microscope (FEI) operated at 200 kV, digital images were
collected using an AMT Advantage XR-12 digital camera.
Cryo-electron microscopy
SARS-CoV was incubated with ACE2 for one hour, and 4 ml
samples were applied to glow-discharged holey carbon films
supported on 400-mesh copper grids. After blotting immediately
for 2–5 seconds with filter paper, grids were plunged into liquid
ethane cooled by liquid nitrogen, using a custom built gravity-
operated freezing device. Specimens were transferred to a Tecnai 20
G2 transmission electron microscope (FEI) operated at 200 kV,
equipped with a Gatan 626.DH low-temperature specimen holder.
Observations were made at temperatures of ,2185uC and images
recorded at 29,0006 magnification on Kodak SO-163 electron
image film at a dose of 10–20 electrons/A ˚ 2 with an exposure of 1–
2 seconds. Film was developed in Kodak D19 for 12 minutes at
room temperature, rinsed for 2 minutes in water, and fixed for
10 minutes with Kodak fixer.
Image processing
The exact magnification in the microscope that SARS-CoV was
imaged at was determined to be 29,9686using a calibration grid
(Pelco International). Images of SARS-CoV were digitized on
a Nikon super coolscan 9000 ED scanner at a pixel size of 2.125A ˚.
Processing was carried out using the EMAN and SPIDER/WEB
image processing program packages [35,45] on SGI Fuel and
Tezro workstations running IRIX 6.5, or a Dell PE6850 with 4-
way 64-bit Xeon Dual Core 3.6 GHz CPUs and 32GB Ram
running Linux (Fedora Core 5). Images were corrected for
contrast transfer function (ctf) using the ‘‘ctfit’’ function in the
EMAN software package, which estimates defocus and corrects for
ctf by phase-flipping. The data set composed of images centred on
SARS-CoV Spike Conformation
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processed using SPIDER by the projection matching approach
[36] which incorporated three-fold symmetry into the search
function and reconstruction procedure. After each refinement
cycle the new reference volume was either theresholded or
segmented using the ‘‘floodfill’’ function in the SITUS software
package [37] to select the spike-ACE2 structure and minimize the
influence of neighbouring spikes in the reference structure that was
used in the subsequent iteration of the projection match
alignment. The initial reference model used in this procedure
was the structure of the SARS spike that we previously solved by
cryo-electron microscopy [21]. The population of spike images
was composed of both side view projections as well as end-on
projections, with the latter being easily identified in the images
with greater defocus values. These high-defocus/end-on images
were essential to eliminate the ‘‘missing cone’’ from the
reconstruction. The resolution of the cryo-EM reconstruction
was estimated by Fourier shell correlation to be 18.5A ˚ using the
0.5 FSC criteria. The structures of the pre-fusion HR2 domain
and the ACE2-receptor-binding domain were docked into the
cryo-EM reconstruction using the ‘‘floodfill’’ and ‘‘colores’’
functions in the SITUS software package. The resultant docking
generated one distinct location for the ACE2-receptor-binding
domain, which placed ACE2 in the additional mass that was not
present in the reconstruction of the spike alone. The docking of the
entire 2FXP.pdb [2] structure was previously conducted [21].
Structure visualisation
Three-dimensional cryo-EM reconstructions, and the atomic
resolution structures 2AJF.pdb [24], 2FXP.pdb [2], were visual-
ized using UCSF Chimera (Computer Graphics Laboratory,
University of California, San Francisco, supported by NIH P41
RR-01081) [46]. The spike component of the spike-viral envelope
reconstruction was segmented from the entire reconstruction using
the ‘‘floodfill’’ algorithm in the SITUS software package. Movie
S1 of the rotating SARS spike-ACE2 complex was generated on
a Silicon Graphics workstation using UCSF Chimera, and the
‘‘mediarecorder’’ and ‘‘mediaconvert’’ software provided with the
Silicon Graphics IRIX 6.5 operating system. Movie S2 showing
the morphing of the spike between the SARS spike and SARS
spike-ACE2 complex was generated using the UCSF Chimera
software package with the ‘‘morph map’’ morphing tool plug-in.
Both reconstructions were masked with a cylindrical mask, which
when applied masked the peripheral boundaries of the SARS-CoV
envelope in both reconstructions.
SUPPORTING INFORMATION
Movie S1 Three-dimensional reconstruction of the of the SARS
spike-ACE2 complex. This movie supplements Figs. 1, 4 showing
both the reconstruction of the spike-ACE2 complex as well as the
location of the docked atomic structures. The movie starts showing
the spike-ACE2 complex viewed from an end-on perspective. The
reconstruction then tilts 90o, followed by a 120o rotation along the
three-fold axis of symmetry of the spike. In the second section of
the movie the cryo-EM reconstruction becomes transparent
revealing the location of the docked atomic structures, followed
by a final rotation of 90o back to the initial end-on perspective.
The following color scheme was used: cryo-EM surface; ACE2,
violet; spike, green; stalk, blue; envelope, beige; nucleocapsid, red.
Atomic Structures: PDB ID code, 2AJF, (SARS spike receptor-
binding domain, red; ACE2, white; ACE2 C-terminus, blue); and
PDB ID code, 2FXP, HR2 fusion core, yellow.
Found at: doi:10.1371/journal.pone.0001082.s001 (7.24 MB
MOV)
Movie S2 Three-dimensional morphing of the SARS spike, and
ACE2 bound structures. This movie supplements Figs. 1, 3
showing the putative structural re-arrangement of the spike as it
binds to ACE2. The movie starts showing the SARS spike and
then gradually morphs to the SARS spike-ACE2 complex, and
back to the SARS spike. The morphing reconstruction is shown
from the side and end-on perspectives, and the mass attributed to
the nucleocapsid is presented without morphing. As one watches
the move play back and forth (this can be done by selecting ‘‘loop’’
in a QuickTime Player) one can see the spike twist by ,5o when
viewed from the end-on perspective, and the spike becomes
squatter by ,10 &#x00C5; when viewed from the side
perspective. The following color scheme was used: cryo-EM
surface; ACE2, violet; spike, green; stalk, blue; envelope, beige;
nucleocapsid, red.
Found at: doi:10.1371/journal.pone.0001082.s002 (3.31 MB
MOV)
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